Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

XRP’s Pivotal Battle at the $2 Threshold

Felix Baarz by Felix Baarz
December 13, 2025
in Analysis, Banking & Insurance, Blockchain, Ethereum & Altcoins, Market Commentary
0
XRP Stock
0
SHARES
57
VIEWS
Share on FacebookShare on Twitter

The digital asset XRP finds itself in a curious predicament. Despite Ripple securing significant regulatory approvals and aggressively expanding its business operations, the token’s market price has failed to reflect these positive developments. Currently trading near $2.04, XRP has shed nearly 15% over the past month, clinging to a crucial support level. This disconnect between strong fundamentals and price stagnation appears largely driven by mounting resistance from the traditional banking sector.

Banking Sector Pushback Creates Headwinds

A renewed clash with established financial institutions is emerging as a primary factor behind the subdued price action. This week, Ripple received conditional approval from the Office of the Comptroller of the Currency (OCC) to establish the “Ripple National Trust Bank.” This milestone places the company under direct federal oversight and bolsters the infrastructure for its planned RLUSD stablecoin.

However, this regulatory victory immediately drew sharp criticism. The American Bankers Association (ABA), led by Rob Nichols, launched a forceful attack against the decision. The banking lobby accused Ripple of engaging in “regulatory arbitrage,” expressing concern that granting bank charters to crypto firms could dilute industry standards. This political counter-movement has introduced market uncertainty, tempering enthusiasm around Ripple’s regulatory progress.

Institutional Accumulation Amidst Market Weakness

The current market divergence is striking. Even as the price struggles, institutional investment continues to flow in. U.S.-listed XRP exchange-traded funds (ETFs) have recorded net inflows for 19 consecutive days, pushing assets under management to approximately $1.18 billion. This pattern suggests large-scale investors are building long-term positions, looking beyond the current sideways trading action.

Should investors sell immediately? Or is it worth buying XRP?

From a technical perspective, XRP is in a delicate position. The Relative Strength Index (RSI) reading of 28.8 indicates oversold conditions, which analysts often view as a potential precursor to a price reversal. Nevertheless, the prevailing market sentiment continues to weigh heavily, preventing the asset from gathering sufficient momentum to break decisively away from the $2 support zone.

Strategic Moves Continue Unabated

Undeterred by political friction, Ripple is pressing forward with its expansion strategy. The company confirmed on Saturday its acquisition of stablecoin infrastructure provider Rail for $200 million. By integrating Rail’s technology, Ripple aims to control the entire stablecoin value chain, from issuance to compliance. In a parallel development, Switzerland’s AMINA Bank announced it is the first regulated European institution to launch real-time payments via Ripple Payments, highlighting the practical utility of the XRP Ledger within banking environments.

The overall market situation remains tense. Investor focus is now fixed on the $2.00 level. If this support holds against the pressure from banking industry opponents, the long-term outlook remains constructive. However, technical confirmation of a bullish shift would only come with a sustained price advance above $2.65, signaling that positive fundamental developments are finally being reflected in the token’s valuation.

Ad

XRP Stock: Buy or Sell?! New XRP Analysis from March 25 delivers the answer:

The latest XRP figures speak for themselves: Urgent action needed for XRP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

XRP: Buy or sell? Read more here...

Tags: XRP
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Ocugen Stock
Analysis

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
IBM Stock
Analysis

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Next Post
Boeing Stock

Boeing's Order Surge Faces Regulatory Hurdles

Adobe Stock

Adobe's AI Ambitions Come at a Cost to Profitability

Palantir Stock

Palantir's Dual Catalysts: Defense Contract and Legal Action Shape Market View

Recommended

BigBearai Holdings Stock

BigBear.ai Faces Critical Test as Revenue Plummets and Losses Mount

6 months ago
D-Wave Quantum Stock

D-Wave Quantum: CFO’s Multi-Million Dollar Exit Amidst Major Capital Raise

4 months ago
Brightcove Stock

Bending Spoons Forges AI-Powered Streaming Future with Brightcove at the Core

6 months ago
Microsoft Stock

Microsoft Faces Critical Earnings Test Amid AI Expectations

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

Trending

Bionxt Solutions Stock
Healthcare

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

by SiterGedge
March 25, 2026
0

BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant...

Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon
  • Ocugen Shares Slide Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com